Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.11 - $147.37 $1,543 - $2.07 Million
14,030 New
14,030 $1,000
Q2 2022

Aug 12, 2022

SELL
$0.18 - $0.31 $2,272 - $3,914
-12,626 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.27 - $0.4 $3,409 - $5,050
12,626 New
12,626 $3,000

Others Institutions Holding NBY

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About NovaBay Pharmaceuticals, Inc.


  • Ticker NBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,988,400
  • Market Cap $46.1M
  • Description
  • NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...
More about NBY
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.